1-855-378-42281-855-378-4228
One of the outpatient rehab alternatives for people in Larimore battling with opioid dependence and addiction is called opioid maintenance therapy. Some facilities and doctors are authorized to administer certain meds to opioid addicted clients, many of which are opioid-based themselves and are addiction. In low doses the user doesn't experience being high but also doesn't have intense cravings and isn't experiencing opioid withdrawal. Methadone is the first drug tried for this purpose, but there are alternative choices currently to select from.
Methadone is an opiate and is meant to be taken at an outpatient medical center licensed to administer the drug, which is taken on a daily basis in liquid or pill form. The price of the drug is approximately $150 per month. Buprenorphine is also an opiate based drug, and is in pill form often taken one day on, one day off. But unlike Methadone that can only be administered in well-regulated medical centers, Buprenorphine can be and is prescribed and dispensed in doctor's offices. The cost monthly of buprenorphine is about $300.00 per month for the generic version of the med. There is also a type of buprenorphine that contains the ingredient naloxone, that is a med that blocks the effects of opiates. An individual consuming this formulation, AKA Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and is priced approximately $450 a month. Naltrexone is another medication used in opioid maintenance therapy, but unlike the other medications aforementioned it is an opioid blocker and isn't an opioid. A person has the choice to take this medication as a monthly shot, which is called Vivitrol. As an opioid blocker, the drug prevents an individual from feeling high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 per month.
For All Alcohol and Drug Treatment Facilities In Larimore, Click Here.
